GL1X · GenesisL1 explorer

Research workbench

Macrolide 2'-phosphotransferase type II - complex with GDP and spiramycin

Analyse Macrolide 2'-phosphotransferase type II - complex with GDP and spiramycin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5IGZ
Type
protein
Length
299 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Macrolide 2'-phosphotransferase II
UniProt
O32553
Ligands
GDP, SPR, MG
Pockets
1 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMacrolide 2'-phosphotransferase IIprotein29948% helix, 16% strandO32553

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • SPR · Spiramycin I · ligand · chains A
  • MG · Magnesium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18390.800.8272GDP, MG, SPR

Compared structures

  • 5IGZ · Macrolide 2'-phosphotransferase type II - complex with GDP and spiramycin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.